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Silicon is a chemical element, which has a 
symbol of Si and an atomic weight value of 28. 
It is not a metal element and it actually has 
semimetallic characteristics, which means that 
silicon does not stand as a single atom, but 
rather as a chemical compound of silicon 
dioxide or a complex compound or silicon 
silicate.1 In addition, silicone is a cross-linked 
polymer with methyl siloxane as the basic 
element. Polydimethylsiloxane (PDMS) is the 
most common silicone, which has been used in 
many kind of preparations such as liquid, gel 
and solid.1,2 Polymerization and the length of 
siloxane chain may affect its viscosity, which is 
measured in units of centistokes (cS). Silicone 
has some degree of resistance to react with 
oxidizing agents, such as nitric acid, sulfuric 
acid, chlorine and other fluids, which are more 
hydrophobic than fluids with similar viscosity to 
silicone.2,3 
In daily life, many people have been exposed to 
silicones in the form of simethicone (antifoams 
used in antacids), silicone oil as a lubricant for 
syringes and cerebrospinal shunt tubes. Silicones 
are also found in cosmetic products such as hair 
conditioner and shampoo to give hair a silky and 
dazzling shine. Moreover, metalloid silicone 
crystals have been used widely for various needs 
such as transistors, electronic microchips, 
computers and household utilities.4  
The use of silicone injection for reconstruction 
of face and other body parts was started in 1963 
with a total of 200 patients in Las Vegas. Severe 
inflammatory effect was noted and therefore, the 
application was stopped. At that time, the type 
of injected-silicon was industrial grade with low 
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Abstract Objective To evaluate silicon level in normal skin tissue. 
 
Methods The silicon levels in skin samples were measured using an atomic absorbance 
spectrophotometer in 37 healthy normal females who had never received silicone injection and 
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however the level is significantly low. 
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effects such as severe inflammation were 
certainly found. Later, the Dow Corning 
Corporation produced sterile and injectable 
silicone with high purity and low viscosity 
(350cS) characteristics.2 Afterwards, in 1977, 
Wilke obtained data of 92 individuals who had 
received the injectable-grade silicone injections 
and noticed that there were inflammatory 
reactions with granuloma formation in 8 
individuals, which developed within a year after 
the injection. Ten years later, granuloma 
formation was also found in the other 13 
individuals. On the contrary, Arohnsohn injected 
subcutaneous silicone in 1984 using pure and 
sterilized-silicon to 4,863 individuals aged over 
22 years. As a result, no side effect was found.2 
Since evidence-based data have been 
inconsistent, particularly regarding the 
indication and adverse effects of silicone use, 
FDA has decided to ban the use of silicone as 
filler material. However, there are still a lot of 
ways of silicon entering our body parts other 
than injection such as through oral pathway into 
digestive system by intake of some foods 
containing high levels of silicon or topical 
pathway by the use of face cream. Our study 
evaluated the silicon levels found in normal skin 
tissue and discussed the possible mechanisms of 
how the molecule can enter and migrate along 
our body systems. There was no prior study has 




37 healthy normal women participated in our 
study. We had requested their approval to 
examine their skin sample obtained from face-
lift procedure. The subjects had never received 
silicone injection and their silicon (Si) levels 
were compared to other subjects who had 
received liquid silicone injection with a 
development of granuloma formation. The skin 
sample of subjects with granuloma were isolated 
from the granuloma tissue located in submental 
area. The skin samples were isolated from of 
facial area of both subject groups. 
Measuring silicon (Si) levels using Atomic 
Absorbance Spectrophotometer 
The skin samples were analyzed and the silicon 
levels were measured using an atomic 
absorbance spectrophotometer (AAS) at an 
analytical chemical laboratory in Faculty of 
Mathematic and Natural Sciences, University of 
Indonesia. The levels were measured as 
microgram of silicon per gram of skin tissue.  
Results 
Figure 1 shows data about the levels of silicone 
in both subject groups. The mean silicon level in 
the skin samples of normal subjects was 
44.07±75.86 µg/g and a 38-fold higher level of 
silicon was found in the skin sample of subjects 
with granuloma (1709.21±1851.72 µg/g). There 
was a significantly higher level of silicon in 
subjects with granuloma as compared to the 
normal subjects. However, there was still a low 
level of silicon  detected  in  the normal subjects.  
 
Figure 1 The level of silicon (Si) in normal subjects 
who had never received silicone injection (never 
injected) and in subjects with granuloma who had 
received silicone injection (injected) 
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In the normal subject group, there were 15 
subjects who had silicone in their skin samples; 
while in the other 22 subjects, no silicon level 
was detected. 
Discussion 
Silicon has been claimed as a stable and inert 
element.5,6 With such unique properties, 
manufacturing companies have been producing 
injectable-grade silicone for medical use. For 
example, transconjunctival injection of silicone 
oil has been used to treat complicated retinal 
detachment and heavy silicone oil tamponade 
has been promising good prognosis for retinal 
reattachment, as well as, improving visual acuity 
and providing successful results on other 
anatomical parameters. Nevertheless, some 
complications such as mild inflammation, 
increased ocular pressure, cataract and heavy 
silicon oil emulsification may arise.7-9 
Silicone oil injection has also been applied to 
reduce the risk of developing diabetic foot ulcer. 
Some other studies have reported that silicone 
oil has pressure-reducing properties and it may 
have a role in increasing plantar tissue 
thickness.10,13 In spite of the advantages, some 
complications may still arise. Another study 
report showed that silicone injection in lower 
extremity could develop palpable nodule around 
injection area, as well as, electrical sensation, 
muscle fatigue, joint pain and electrical 
neuropathy.14 In addition to those local 
complications, systemic complications have also 
been reported including lymphadenopathy, renal 
disease and hepatic disease. It indicates that 
injected silicone can migrate from injection site 
to other body parts. In experimental mice model, 
the injected silicone could be engulfed by 
macrophages in skin tissue, recirculated via 
lymphatic vessels and accumulated in adrenal 
glands, lymph nodes, liver, spleen and kidney.15 
In diabetic ulcer patients, migration of silicone 
that has been implanted into their foot may be 
correlated with biomechanic activity of foot 
itself. 
Granuloma formation due to silicone injection is 
dose-dependent. Figure 1 shows that only a 
large amount of silicon caused granuloma 
formation as there was a low level of silicon in 
the skin tissue of normal subjects, but no 
granuloma formation was documented. 
In addition to its medical application, silicone 
has also been used in food, cosmetics and 
pharmaceutical industries. Previous data 
demonstrated that the silicon (Si) levels in 
digestive drugs such as antacids, mineral water 
and soft drink was 44.1, 25.6, and 2.91 µg/g 
silicone, respectively. Therefore, we can say that 
there are a lot of routes of silicone entering into 
our body. 
The average daily dietary intake of silicon is 20-
50 mg for European and North American 
populations. Daily intake of silicon is higher in 
China and India (140-200 mg/day) where grains, 
fruits and vegetables form a larger part of the 
diet.1 
Recently, a research institution of healthy aging 
and nutrition in UK has reported a strong 
correlation between silicon diet and the health of 
bone and connective tissue. It is assumed that 
the correlation is associated with collagen 
synthesis and/or stabilization, as well as, 
mineralization of the matrix, in which silicone 
intake has some effects on bone density.16 
An animal experimental study, showed that there 
was no evidence about silicone accumulation in 
oral silicone intake. Silicone can be eliminated 
by numerous routes including feces (93-97%), 
urine (0.001-0.22%) and exhaled air (0.01-
0.02%).3 It indicates that silicone is a stable 
element and can have a certain degree of 
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resistance against enzyme digestion, as well as, 
acidic gastric condition. Therefore, it is unlikely 
for silicone to accumulate in gastrointestinal 
system.  
Beauty products for face, hair and cosmetics 
may contain a higher level of silicone, which is 
more likely to be accumulated in skin tissue. 
When topical silicone products are applied to the 
skin, silicone elastomeric particles can absorb 
various liquids including emollient and sebum. 
Therefore, it can be used for skin care as 
delivery vehicles for some active ingredients to 
the skin or to control sebum deposition in the 
skin.17 
The capability of silicone elastomeric particles 
to expand in certain solvents has prompted their 
utility as therapeutic delivery agent for skin care. 
This unique capability and in addition to the 
surface area of silicone elastomeric particles can 
absorb various kind of oils and make the skin 
stay dry when it is touched. Therefore, the 
silicone elastomeric particles can be used as an 
agent to carry certain oil or ingredients or as 
emollient for the skin and act as mineral oil, 
glycerides, fat esters and sunscreen.18  
Silicone elastomeric particles, which are covered 
by nanoparticles such as  Al2O3 or TiO2, have 
shown soft-focus effect. In a simple description, 
it can be said that the soft-focus effect becomes 
obvious when there is minimum reflection 
(<20% of total illumination), maximum total 
transmission (>75% of total illumination); while 
the disperse illumination reflection is maximum 
(80%) and the disperse illumination has 
maximum transmission (>50%).17 
When these criteria are fulfilled, the total 
transmission illumination reflects natural skin 
tone similar to the back light effect and provides 
natural light; while the disperse transmission 
will even create better skin glow and hides 
imperfection.18 Silicone elastomeric particles, 
which have been enhanced with SiO2 particles 
have been proven to minimize wrinkles.17  
Silicon accumulation in the skin is probably 
caused by topical use of applying cosmetic 
products, which contain silicone. The 
penetration of chemicals that are contained in 
cosmetic products is influenced by molecular 
size, lipophilicity, pH, penetrant concentration, 
chemical enhancers, skin hydration, skin 
enzymes, and temperature. Manipulating these 
parameters could be drive the dermatokinetic of 
chemical compounds that are contained in 
cosmetic products.18 
In skin cream, silicon could form water-repellent 
layer to protect skin. Nonetheless, silicon has a 
large molecular size and it is impossible for 
silicon to penetrate skin layer without any 
enhancer. Another ingredient contained in the 
skin cream can enhance silicon penetration into 
deeper layer of the skin. Low level of silicon 
found in the skin tissue of normal subjects in our 
study might be caused by daily use of skin 
cream. Thus, it is unlikely that normal subjects 
have no silicon level in their skin. Therefore, 
greater consideration must be taken in new 
technology on absorption mechanism when 
applying topical cream on the skin including 
nanotechnology, which can penetrate into the 
skin and in the long-term it may develop into 
granuloma. 
Conclusion  
The use of silicone as filler material has been 
banned by FDA. Nevertheless, there are still 
some risks of using topical silicone, particularly 
cosmetic products that contain silicone. 
Bioavailability of silicone in skin tissues and 
long-term complications of silicone use must be 
evaluated for safety reasons. Moreover, further 
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studies should be done on how silicon can 
penetrate into skin tissue.  
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